{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:23:05Z","timestamp":1792783385622,"version":"4.5.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T00:00:00Z","timestamp":1790294400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T00:00:00Z","timestamp":1790294400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Ondokuz May\u0131s University Scientific Research Project Office","id":[{"id":"https:\/\/ror.org\/028k5qw24","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"DOI":"10.1007\/s12032-026-03403-6","type":"journal-article","created":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T05:30:35Z","timestamp":1790314235000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Antibiotic-chemotherapy interaction in brain tumors: cefazolin reduces chemotherapeutic efficacy of irinotecan in glioblastoma and neuroblastoma cells"],"prefix":"10.1007","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-8918-7839","authenticated-orcid":false,"given":"\u0130layda","family":"\u015ei\u015fli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3791-838X","authenticated-orcid":false,"given":"Melek","family":"Y\u00fcce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9114-6253","authenticated-orcid":false,"given":"Esra","family":"Albayrak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,25]]},"reference":[{"issue":"1","key":"3403_CR1","first-page":"10","volume":"75","author":"RL Siegel","year":"2025","unstructured":"Siegel RL, et al. Cancer statistics, 2025. Ca. 2025;75(1):10.","journal-title":"Ca"},{"issue":"3","key":"3403_CR2","first-page":"223","volume":"4","author":"L Li","year":"2024","unstructured":"Li L, et al. Nowcasting and forecasting global aging and cancer burden: analysis of data from the GLOBOCAN and Global Burden of Disease Study. J Natl Cancer Cent. 2024;4(3):223\u201332.","journal-title":"J Natl Cancer Cent"},{"key":"3403_CR3","doi-asserted-by":"publisher","first-page":"102716","DOI":"10.1016\/j.canep.2024.102716","volume":"95","author":"R Shah","year":"2025","unstructured":"Shah R, et al. Updated cancer burden in oldest old: A population-based study using 2022 Globocan estimates. Cancer Epidemiol. 2025;95:102716.","journal-title":"Cancer Epidemiol"},{"issue":"8","key":"3403_CR4","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1038\/s41571-023-00776-9","volume":"20","author":"MB Lustberg","year":"2023","unstructured":"Lustberg MB, et al. Mitigating long-term and delayed adverse events associated with cancer treatment: implications for survivorship. Nat Reviews Clin Oncol. 2023;20(8):527\u201342.","journal-title":"Nat Reviews Clin Oncol"},{"key":"3403_CR5","doi-asserted-by":"publisher","first-page":"245","DOI":"10.3389\/fphar.2018.00245","volume":"9","author":"K Nurgali","year":"2018","unstructured":"Nurgali K, Jagoe RT, Abalo R. Adverse effects of cancer chemotherapy: Anything new to improve tolerance and reduce sequelae? Front Pharmacol. 2018;9:245.","journal-title":"Front Pharmacol"},{"issue":"10","key":"3403_CR6","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/S1470-2045(03)01218-X","volume":"4","author":"S Vento","year":"2003","unstructured":"Vento S, Cainelli F. Infections in patients with cancer undergoing chemotherapy: aetiology, prevention, and treatment. Lancet Oncol. 2003;4(10):595\u2013604.","journal-title":"Lancet Oncol"},{"issue":"5","key":"3403_CR7","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1080\/08880018.2017.1396386","volume":"34","author":"SB Whittle","year":"2017","unstructured":"Whittle SB, Williamson KC, Russell HV. Incidence and risk factors of bacterial and fungal infection during induction chemotherapy for high-risk neuroblastoma. Pediatr Hematol Oncol. 2017;34(5):331\u201342.","journal-title":"Pediatr Hematol Oncol"},{"issue":"10","key":"3403_CR8","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1056\/NEJMoa050078","volume":"353","author":"M Cullen","year":"2005","unstructured":"Cullen M, et al. Antibacterial prophylaxis after chemotherapy for solid tumors and lymphomas. N Engl J Med. 2005;353(10):988\u201398.","journal-title":"N Engl J Med"},{"issue":"6","key":"3403_CR9","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1016\/S1473-3099(16)30056-1","volume":"16","author":"B Liss","year":"2016","unstructured":"Liss B, Cornely OA. Burden and benefit of antibiotic prophylaxis in cancer chemotherapy. Lancet Infect Dis. 2016;16(6):640.","journal-title":"Lancet Infect Dis"},{"issue":"6","key":"3403_CR10","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1093\/annonc\/mdy103","volume":"29","author":"L Derosa","year":"2018","unstructured":"Derosa L, et al. Negative association of antibiotics on clinical activity of immune checkpoint inhibitors in patients with advanced renal cell and non-small-cell lung cancer. Ann Oncol. 2018;29(6):1437\u201344.","journal-title":"Ann Oncol"},{"issue":"17","key":"3403_CR11","doi-asserted-by":"publisher","first-page":"5135","DOI":"10.7150\/jca.47470","volume":"11","author":"Y Gao","year":"2020","unstructured":"Gao Y, et al. Antibiotics for cancer treatment: A double-edged sword. J Cancer. 2020;11(17):5135.","journal-title":"J Cancer"},{"key":"3403_CR12","doi-asserted-by":"publisher","first-page":"E01","DOI":"10.1016\/j.cpt.2025.02.005","volume":"3","author":"A Upadhyay","year":"2025","unstructured":"Upadhyay A, et al. Repurposing antibiotics: A dual-action approach against bacteria-induced cancer. Cancer Pathogenesis Therapy. 2025;3:E01\u201311.","journal-title":"Cancer Pathogenesis Therapy"},{"issue":"1","key":"3403_CR13","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1093\/toxsci\/kfq085","volume":"116","author":"C-H Li","year":"2010","unstructured":"Li C-H, et al. Chloramphenicol causes mitochondrial stress, decreases ATP biosynthesis, induces matrix metalloproteinase-13 expression, and solid-tumor cell invasion. Toxicol Sci. 2010;116(1):140\u201350.","journal-title":"Toxicol Sci"},{"key":"3403_CR14","doi-asserted-by":"publisher","first-page":"1065994","DOI":"10.3389\/fonc.2023.1065994","volume":"13","author":"H Chi","year":"2023","unstructured":"Chi H, et al. Opportunities and challenges related to ferroptosis in glioma and neuroblastoma. Front Oncol. 2023;13:1065994.","journal-title":"Front Oncol"},{"issue":"1","key":"3403_CR15","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s00431-023-05273-w","volume":"183","author":"J Du","year":"2024","unstructured":"Du J, Yuan X. Analysis of the incidence, characteristics, and risk factors of complications during induction chemotherapy in children with high-risk neuroblastoma. Eur J Pediatrics. 2024;183(1):185\u2013202.","journal-title":"Eur J Pediatrics"},{"issue":"1","key":"3403_CR16","doi-asserted-by":"publisher","first-page":"vdae170","DOI":"10.1093\/noajnl\/vdae170","volume":"6","author":"L G\u00f6tz","year":"2024","unstructured":"G\u00f6tz L, et al. Effect of antibiotic drug use on outcome and therapy-related toxicity in patients with glioblastoma\u2014A retrospective cohort study. Neuro-Oncology Adv. 2024;6(1):vdae170.","journal-title":"Neuro-Oncology Adv"},{"issue":"9","key":"3403_CR17","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1007\/s11626-018-0288-9","volume":"54","author":"J Namkaew","year":"2018","unstructured":"Namkaew J, et al. Combined effects of curcumin and doxorubicin on cell death and cell migration of SH-SY5Y human neuroblastoma cells. Vitro Cell Dev Biology-Animal. 2018;54(9):629\u201339.","journal-title":"Vitro Cell Dev Biology-Animal"},{"issue":"7","key":"3403_CR18","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1016\/j.neuint.2012.08.002","volume":"61","author":"MM Hossain","year":"2012","unstructured":"Hossain MM, Banik NL, Ray SK. Synergistic anti-cancer mechanisms of curcumin and paclitaxel for growth inhibition of human brain tumor stem cells and LN18 and U138MG cells. Neurochem Int. 2012;61(7):1102\u201313.","journal-title":"Neurochem Int"},{"issue":"1","key":"3403_CR19","doi-asserted-by":"publisher","first-page":"10660","DOI":"10.1038\/s41598-025-94858-6","volume":"15","author":"F Karamifard","year":"2025","unstructured":"Karamifard F, Dadbinpour A, Mazaheri M. An in-vitro measurement for the toxicity of peptides inhibit hexokinase II in breast cancer cell lines. Sci Rep. 2025;15(1):10660.","journal-title":"Sci Rep"},{"issue":"1","key":"3403_CR20","doi-asserted-by":"publisher","first-page":"32066","DOI":"10.1038\/s41598-025-16692-0","volume":"15","author":"M Y\u00fcce","year":"2025","unstructured":"Y\u00fcce M, et al. Eco-friendly synthesis of silver nanoparticles using Anemone coronaria bulb extract and their potent anticancer and antibacterial activities. Sci Rep. 2025;15(1):32066.","journal-title":"Sci Rep"},{"issue":"5","key":"3403_CR21","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1038\/bjc.2013.48","volume":"108","author":"R Van Leeuwen","year":"2013","unstructured":"Van Leeuwen R, et al. Prevalence of potential drug\u2013drug interactions in cancer patients treated with oral anticancer drugs. Br J Cancer. 2013;108(5):1071\u20138.","journal-title":"Br J Cancer"},{"issue":"4","key":"3403_CR22","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1111\/j.1365-2796.2001.00892.x","volume":"250","author":"I Buajordet","year":"2001","unstructured":"Buajordet I, et al. Fatal adverse drug events: the paradox of drug treatment. J Intern Med. 2001;250(4):327\u201341.","journal-title":"J Intern Med"},{"issue":"2","key":"3403_CR23","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1208\/s12248-009-9106-3","volume":"11","author":"L Zhang","year":"2009","unstructured":"Zhang L, et al. Predicting drug\u2013drug interactions: an FDA perspective. AAPS J. 2009;11(2):300\u20136.","journal-title":"AAPS J"},{"issue":"1","key":"3403_CR24","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s40121-017-0146-1","volume":"6","author":"KV Rolston","year":"2017","unstructured":"Rolston KV. Infections in cancer patients with solid tumors: a review. Infect Dis therapy. 2017;6(1):69\u201383.","journal-title":"Infect Dis therapy"},{"issue":"25","key":"3403_CR25","doi-asserted-by":"publisher","first-page":"4129","DOI":"10.1200\/JCO.2005.03.9909","volume":"24","author":"J Klastersky","year":"2006","unstructured":"Klastersky J, et al. Outpatient oral antibiotics for febrile neutropenic cancer patients using a score predictive for complications. J Clin Oncol. 2006;24(25):4129\u201334.","journal-title":"J Clin Oncol"},{"issue":"1","key":"3403_CR26","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1002\/ijc.11528","volume":"108","author":"K Shiozawa","year":"2004","unstructured":"Shiozawa K, et al. Reversal of breast cancer resistance protein (BCRP\/ABCG2)-mediated drug resistance by novobiocin, a coumermycin antibiotic. Int J Cancer. 2004;108(1):146\u201351.","journal-title":"Int J Cancer"},{"issue":"2","key":"3403_CR27","first-page":"291","volume":"9","author":"M Falchi","year":"1989","unstructured":"Falchi M, et al. Antibacterial and cytotoxic effect of ceftazidime-mitoxantrone association. Anticancer Res. 1989;9(2):291\u20132.","journal-title":"Anticancer Res"},{"issue":"7","key":"3403_CR28","first-page":"1670","volume":"33","author":"RF Zager","year":"1973","unstructured":"Zager RF, Frisby SA, Oliverio VT. The effects of antibiotics and cancer chemotherapeutic agents on the cellular transport and antitumor activity of methotrexate in L1210 murine leukemia. Cancer Res. 1973;33(7):1670\u20136.","journal-title":"Cancer Res"},{"key":"3403_CR29","volume-title":"StatPearls [Internet]","author":"T Bui","year":"2024","unstructured":"Bui T, Patel P, Preuss CV. StatPearls [Internet]. Cephalosporins: StatPearls Publishing; 2024."},{"issue":"12","key":"3403_CR30","doi-asserted-by":"publisher","first-page":"2548","DOI":"10.1093\/carcin\/bgs283","volume":"33","author":"X Li","year":"2012","unstructured":"Li X, et al. Ceftriaxone, an FDA-approved cephalosporin antibiotic, suppresses lung cancer growth by targeting Aurora B. Carcinogenesis. 2012;33(12):2548\u201357.","journal-title":"Carcinogenesis"},{"issue":"1","key":"3403_CR31","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1186\/s12885-015-1560-y","volume":"15","author":"V Yadav","year":"2015","unstructured":"Yadav V, et al. Moxifloxacin and ciprofloxacin induces S-phase arrest and augments apoptotic effects of cisplatin in human pancreatic cancer cells via ERK activation. BMC Cancer. 2015;15(1):581.","journal-title":"BMC Cancer"},{"issue":"3","key":"3403_CR32","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1111\/j.1476-5381.2009.00161.x","volume":"157","author":"LA Bourikas","year":"2009","unstructured":"Bourikas LA, et al. Ciprofloxacin decreases survival in HT-29 cells via the induction of TGF\u2010\u03b21 secretion and enhances the anti\u2010proliferative effect of 5\u2010fluorouracil. Br J Pharmacol. 2009;157(3):362\u201370.","journal-title":"Br J Pharmacol"},{"key":"3403_CR33","doi-asserted-by":"publisher","first-page":"119457","DOI":"10.1016\/j.lfs.2021.119457","volume":"277","author":"X He","year":"2021","unstructured":"He X, et al. Cephalosporin antibiotics specifically and selectively target nasopharyngeal carcinoma through HMOX1-induced ferroptosis. Life Sci. 2021;277:119457.","journal-title":"Life Sci"},{"issue":"1","key":"3403_CR34","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/s12885-021-09125-4","volume":"22","author":"C Pfab","year":"2022","unstructured":"Pfab C, et al. Ceftazidime and cefepime antagonize 5-fluorouracil\u2019s effect in colon cancer cells. BMC Cancer. 2022;22(1):125.","journal-title":"BMC Cancer"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-026-03403-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12032-026-03403-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-026-03403-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T05:30:37Z","timestamp":1790314237000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12032-026-03403-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,25]]},"references-count":34,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2026,11]]}},"alternative-id":["3403"],"URL":"https:\/\/doi.org\/10.1007\/s12032-026-03403-6","relation":{},"ISSN":["1559-131X"],"issn-type":[{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,25]]},"assertion":[{"value":"29 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors have provided their consent to the publication of this manuscript.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethics and Consent to Participate declarations: not applicable.","order":3,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"302"}}